Skip to main content

Home/ Pharmaceutical Laboratory/ Group items tagged US

Rss Feed Group items tagged

hamelinclara

20 hospitals with inspiring social media strategies | Articles | Home - 0 views

  • 1. Mayo Clinic The Mayo Clinic has long been an online resource for medical information, with a website that offers advice and expertise from more than 3,300 medical professionals for free, so it’s not at all surprising that the medical group has been successful in social media
  • Doctors were able to share and connect with readers and patients through a first-hand account of relief efforts performed after the 2010 Haiti earthquake.
  • Massachusetts General Hospital recognizes this, and did something amazing when researchers from the Emergency Department worked together to create an iPhone app designed to help users find the closest emergency room to their area anywhere in the U.S. The app was promoted using hospital social media outlets, creating a YouTube video that bloggers could embed in their stories, also providing for opportunities to tweet the video and share it on Facebook. With the help of social media, the hospital’s app was able to stand out in the sea of apps available for the iPhone.
  • ...17 more annotations...
  • During the Ft. Hood shooting crisis, one of the hospitals treating victims, Scott & White, took it upon themselves to share updates with the community. Employee Steven Widman offered updates on emergency room access, hospital operation status, and more, also updating with Red Cross news and sharing communications with reporters. The crisis pushed Scott & White’s communications to the forefront of social media, increasing their Twitter followers by 78 percent in only three days, turning Scott & White Healthcare into a Twitter "trending topic," and ranking the hospital’s YouTube channel among the most viewed non-profit channels during the crisis. Both people who were affected and those who were tuned in from afar were able to get real-time updates, thanks to the efforts of Widman and the ability of social media to share information.
  • Nebraska Medical Center has created an incredible YouTube presence, one so successful, that as 360 Digital Influence points out, they’ve had an increase in requests for one surgery in particular. It’s all thanks to a patient who shared her cancer experience on YouTube, which led to so many requests for the surgery she had to treat her rare carcinoid cancer that NMC had to open a monthly clinic for the condition. The medical center encourages patients to share their experience, and even makes use of QR codes to share videos of physicians introducing themselves to potential patients.
  • Connecting with patients and community members is great, but what if you could use social media to do something really amazing, like raise more than $1 million for a new children’s hospital? UCSF did just that, taking on a social media fundraising contest named Challenge for the Children. About 165,000 people blew past the hospital’s initial $100,000 fundraising goal thanks to social media channels including Facebook and Twitter. Much of the campaign’s success ($805,554 worth) was thanks to the Facebook game FarmVille, which allowed players to purchase virtual candy cane seeds that sent 100 percent of the profits to the challenge. This amazingly successful challenge paved the way for a new children’s hospital in Mission Bay, set for completion in 2014, and the top two teams will be honored with the naming of a dedicated space in the hospital.
  • t’s so important to be relevant to the topic at hand in social media, and getting off course can turn off would-be fans. But WakeMed Health & Hospitals in Raleigh, North Carolina made a smart move in April 2011, sharing a time-lapse video shot from the hospital’s helipad that showed a tornado as it passed through the area. Although the tornado is a non-medical story not directly related to the hospital’s mission, hospitals are a vital part of any community, and in sharing this video, WakeMed further cemented itself as a valuable resource for the Raleigh area. Med City News praised WakeMed for the video, pointing it out as one of the top blog entries for the medical group. As WakeMed spokeswoman Heather Monackey shares, they’ve found success in social media because they "just pay attention to what’s going on."
  • Hospitals are using social media to connect internally, in addition to community building. At Texas Health Resources, social media tools make it possible for physicians and other health professionals to engage with each other and take advantage of useful tools. Using social media, Texas Health Resources promotes the adoption of electronic health records, and integrates the use of the private microblogging site Yammer to share internal messages, how-to videos, and more. Project managers and physicians use social media tools like Yammer to come together, collaborate, and communicate effectively over a large hospital system.
  • ealth care social media isn’t just about attracting patients and building community, at least not for Geisinger Health System in Danville, Pennsylvania. The health system typically turned to ads in medical journals and direct mail to recruit gastroenterologists, but when they had trouble getting enough responses, associate vice president of marketing Cathy Connolley turned to social media to recruit their physicians. With the help of a recruitment marketing firm, Geisinger created a social media physician recruitment campaign, creating a convenient and cost-effective way to communicate with physicians, and an easy way to direct gastroenterologists to their Facebook page. As Connolley reports, "that tactic outpaced our direct mail approach and our email blasts."
  • Live-tweeting brain surgery just sounds like crazy talk, but Henry Ford Hospital near Detroit made it work. While performing surgery on a 47-year-old man, doctors discussed the procedure with more than 1,900 people, and even uploaded video of the surgery to YouTube. Things seem to go to the next level when the answer to Twitter’s "What are you doing?" question is brain surgery. The hospital earned praise and attention from ABC News, and showed off just how well they can make use of social media. In addition to Twitter brain surgeries, Henry Ford Hospital makes use of news feeds, Flickr, and blogging to reach patients and the general community.
  • Scripps makes it a point to connect with patients and customers through the use of social media. In an interview with Found In Cache, Scripps director of web technology Marc Needham shared that the hospital typically spends its social media time on customer service. In fact, Scripps developed a new position of Electronic Customer Service Representative, specifically created to reach out to patients through social media and respond to online reviews. Needham pointed out that Scripps believes it’s important to have a good handle on their online brand perception, and left unchecked, "unaddressed complaints fester and lead to online reputation rot." Scripps has found success in this pursuit, but Needham says they haven’t quite defined their social media approach just yet, and they’re still experimenting with a variety of different sites, including Wikipedia, YouTube, Flickr, Facebook, and LinkedIn. Scripps tends to use different sites for different purposes, like Facebook for recruitment and LinkedIn for employee connections.
  • hildren’s Hospital Boston has a wildly popular Facebook page. A Facebook page alone isn’t quite enough to be truly impressive these days, but Children’s Hospital Boston really stands out, not just for its half a million plus fans, but really for its top-notch content. Their landing page has information people really want to read, and an encouraging atmosphere that gets patients and fans to open up and share their stories. This high level of engagement is truly inspiring, and offers a great lesson for any Facebook Page owner. Through photos of the week, Children’s Hospital Boston highlights families and patients, who in turn spread the word to their friends and family on Facebook, bringing fans and patients to the Facebook Page to interact. But, as Ignite Social Media points out, Children’s Hospital Boston does so much more than Facebook, effectively managing a Twitter feed and YouTube video collection as well.
  • arasota Memorial Hospital understands the value to building better relationships through social media. In an interview with The Side Note, the hospital’s market research manager Shawn Halls shared how it came to begin using social media as an important tool. After growth and more than three years of use, Sarasota Memorial now sees Twitter and other sites as an important part of their communications strategy, using social media as a way for the community to directly communicate with the hospital. The hospital encourages patients to direct message their Twitter account, and has even been able to connect patient family members with resources like local florists through the site. Like other hospitals, Sarasota Memorial also has plans to share surgery via Twitter, specifically a brain mapping procedure where the patient is awake.
  • Social media is great for spreading news, but it’s also a useful tool for correcting misinformation as well. The Greater Baltimore Medical Center knows that fact all too well, as in August 2010, a Baltimore TV station incorrectly reported that the hospital had been invaded by an armed robber. GBMC media relations manager Michael Schwartzberg was able to act quickly to correct the mistake, sending out a swift collection of tweets that set the story straight for the public and concerned citizens. With active social media accounts already in place, the foundation for sharing information was set and easy to take advantage of, something that the hospital utilizes frequently. Schwartzberg reports that in addition to media relations and customer service, GBMC uses social media as a valuable way to share crisis communication, much like their fake armed robber, H1N1 updates, and if need be, disaster reporting.
  • Just like GBMC, Inova Health found value in Twitter’s ability to set incorrect information straight. Inova uses a security system designed to prevent the theft of babies from maternity wards, and as hospital personnel ran a test of the system, a visitor heard it and mistakenly believed that there was a lost baby. That same visitor then tweeted about the non-incident. Director of digital communications and marketing Chris Boyer had wisely set up social media monitoring services, and quickly spotted the tweet within just minutes of posting. After calling to confirm that there was not actually a problem, Boyer was able to immediately respond on Twitter and share the hard facts of the story, helping to preserve the hospital’s reputation before things got really crazy. Inova Health’s story shows just how important it is to use tools that can help you monitor and stay on top of your social media presence.
  • Living organ donation is an amazing gift and process, and Children’s Medical Center was able to share a special family’s story through Twitter. As a Texas firefighter donated his kidney to his three-year-old son, the Twitterverse was able to follow along with their successful story from start to finish, shared by none other than the mom and wife. With nearly 85,000 people on the waiting list for a kidney, Children’s Medical Center media relations manager Jessica Newell hopes that "twittering from this surgery will help raise awareness for organ donation, as well as living organ donation."
  • Twitter and social media in general can be a scary thing for hospitals, opening up issues of liability and uncomfortable situations. But at least at the University at Buffalo School of Medicine and Biomedical Sciences, doctors and professors recognize Twitter as an incredibly valuable tool for learning and training. Dr. Philip L. Glick shares his insight: "[A] lot of the training consists of passing on information, lessons learned, and wisdom to the next generation. Twitter allows us to dramatically scale up our ability to do this. When I post something on Twitter, all the pediatric surgeons, trainees and colleagues in the country and the world can see it instantly." In addition to small updates, University at Buffalo uses social media to share audio and video of procedures, breaking them down into small pieces that offer opportunities for sharing and teaching. 18. St. Luke’s Cedar Rapids
  • Anxious groups of families and friends sit in hospital waiting rooms across the country, hoping to hear updates and news that their loved one is doing well. Some will find out about things as they go along, some simply when procedures are over. The level of information shared largely depends on the capacity and availability of the team of medical professionals at work. With Twitter, the time and energy necessary to share updates with loved ones is significantly decreased, and small, frequent updates can be shared in just moments, creating an opportunity for hospitals to better inform worried waiting rooms as things go along. At St. Luke’s Cedar Rapids, one family was able to enjoy this incredible level of customer service, as their 70-year-old mother Monna Cleary underwent a hysterectomy and uterine prolapse surgery. Cleary had given her OK for the hospital to share a play-by-play of her operation, and hospital spokeswoman Sarah Corizzo shared more than 300 tweets, allowing the family to follow along, and informing the general public. Corizzo answered questions, and fascinated nearly 700 people who followed along with the surgery. Hospital spokeswoman Laura Rainey pointed out that live-tweeting is a "more gentle" way to inform patients and consumers, allowing them to follow what’s going on without shocking visuals. Cleary’s son Joe and his siblings appreciated the opportunity, pointing out that "it made the time go by," and they enjoyed having real-time information and staying informed while in the waiting room.
  • haring information during a crisis is vital, even when you don’t have a lot of time or resources to do it. So when more than 50 people had to go to hospitals for treatment following a chemical fume exposure at a trash disposal station, Southcoast Hospital turned its Twitter account into a "crisis communication portal," sharing status updates for more than a week. Updates included status on admitted, discharged, and treated patients during the spill, and helpful information and links that kept the public and concerned loved ones constantly updated during the situation.
  • Hospitals are full of stories that the community is interested in, with people overcoming great odds and going on to live healthier lives. At Barnes-Jewish Hospital, a 23-year-old heart transplant patient Megan Moss attracted lots of local interest, thanks to updates from the Barnes-Jewish Hospital blog, Touching Base. Additionally, Megan’s dad shared constant updates through his own blog. Moss’s story attracted so much attention, that one weekend, she got 75 emails through the hospital’s website with well wishes from friends, family, and strangers alike. Through numerous updates and even a video interview with the hospital’s director of heart transplant, both Moss and Barnes-Jewish got much deserved attention within the community.
hamelinclara

MARCHÉ PHARMA: Vers une offre de service autour du médicament - IMS Health | ... - 0 views

  • MARCHÉ PHARMA: Vers une offre de service autour du médicament – IMS Health Publié le 17/06/2011 Sélectionner une langue​▼ Nouveaux marché émergents et stabilité en Europe, nouveaux segments de produits et surtout nouvelles exigences de l'ensemble des acteurs du système de santé, des Autorités sanitaires au patients en incluant aujourd'hui l'ensemble des professionnels de santé, le tout dans un contexte économique tendu, ce rapport d'IMS Health souligne, à destination des laboratoires pharmaceutiques, la nécessité d'adapter, en permanence, leurs stratégies marketing. On retiendra en particulier la notion de progrès médical dans l'innovation et de service autour du médicament qui doit désormais être intégrée dans l'offre pharmaceutique.
  • Des marchés émergents: Avec le tassement des marchés matures, les Etats‐Unis notamment devraient être remplacés par la Chine, prochain principal contributeur à la croissance mondiale avec le Brésil, la Russie, l'Inde, l'Asie du Sud‐Est et l'Amérique Latine.
  • Des pathologies émergentes: Cette étude publiée par IMS Health souligne, pour l'Europe, l'augmentation du segment des médicaments de spécialistes au dépens du segment des médicaments de généralistes.  Alzheimer, épilepsie,  Parkinson,  sclérose en plaques, ces grandes pathologies en neurologie devraient faire l'essentiel de la croissance du marché (7 % pour les « spécialistes », contre 5 % pour les « généralistes).
  • ...2 more annotations...
  • En France, pas de croissance: « Le marché français reflète la tendance observée à l'international sur les marchés matures”, relève le rapport. La croissance est quasi nulle en 2010 et le sera probablement en 2011. Le marché hospitalier qui affichait une croissance à deux chiffres au début des années 2000, 6 % en 2009, ne progresse que de 2 % en 2010. Le marché des génériques qui représente 14 % en valeur, doit digérer deux nouvelles molécules (atorvastatine, esoméprazole) non encore génériquées qui soutiendront son dynamisme qui contribue à la stabilité générale en valeur du marché français. Le marché de « l'automédication » (OTC) est lui qualifié d'atone, avec des prix stables et une demande également stable, liée à la crise économique et à la crise de confiance du médicament certainement.
  • La perspective d'une évaluation post-AMM européenne? L'intégration européenne de l'évaluation du médicament post‐AMM pourrait être envisagée même si la France, l'Allemagne et le Royaume‐Uni militent plutôt en faveur du statu quo et d'une autonomie de décision, évoque l'économiste Claude Le Pen. Dans ce cas, l'approche serait économique avant d'être clinique ou médicale
hamelinclara

International Research - Brazil - Research and Trends - PMMI - 0 views

  • PHARMACEUTICAL INDUSTRY ANALYSIS Brazil has the 11th largest pharmaceutical market globally with annual sales topping US$17bn. Brazil launched a major 10-year biotechnology initiative in 2007 that provides incentives for private-sector R&D and production. There are some 550 pharmaceutical firms in Brazil. Of the top ten companies by sales in 2008, the first six are all foreign multinational drug makers. Sanofi-Aventis (US$1,229mn in sales) and Novartis (US$1,116mn) are clear leaders, followed by Roche (US$735mn), Pfizer (US$666mn) AstraZeneca (US$584mn) and Eli Lilly (US$545mn). Local firms Aché (US$456mn), EMS Sigma Pharma (US$445mn), Eurofarma (US$424mn) and Biosintética (US$382mn) fill the remaining spots. While this shows the strength of innovation for foreign drugmakers, the presence of five local firms highlights strong competition, as well as the growing use of generic drugs in Brazil. Other leading local producers include Aché/Biosintética, Medley and Libbs. From 2009-2014 BMI forecasts a CAGR of 11.63% for patented drug market in US dollar terms. The projected continuation of sales expansions is one of the key reasons that multinational research-based drugmakers continue to invest in Brazil despite generic competition having eroded some market potential since their inception in 2000. Industry association PróGenéricos has estimated that generics will account for 30% of the market by 2010. Investment reportedly totaled around US$400mn between 1999 and 2006, illustrating not only an expansion of capacity, but also the repositioning of product lines in favor of genuine generics. SOURCE: Business Monitor International
hamelinclara

The search for blockbuster drugs - McKinsey Quarterly - Health Care - Pharmaceuticals - 1 views

  • "me-too" compounds,
  • heir efficacy, or comparative effectiveness in treating a specific disease
  • safety, including issues such as side effects and drug interactions
  • ...10 more annotations...
  • the breadth of their approved uses
  • convenience, including longer-lasting formulas and easier application
  • highly effective,
  • costly and inconclusive.
  • By contrast, many companies have had more success with efforts to improve the safety of products or to get them approved for use in treating additional diseases. Examples are Pfizer's Neurontin, a successful antiepilepsy medication driven predominantly by perceptions of safety differences, and the company's Celebrex, a Cox-2 inhibitor that reduces pain and inflammation and is thought to be easier on the stomach than aspirin. The breadth of approved uses for drugs can also be a significant source of differentiation. We found that nearly two-thirds of those in competitive therapeutic areas, such as depression and allergies, went on to receive regulatory approval for a broader range of treatments after they came on the market (Exhibit 2). Eli Lilly's Prozac, for example, was launched in 1987 to treat depression but has since been approved for use in a range of conditions. Today, drugs entering these competitive areas often need to have a similarly broad range of regulatory endorsements at the time of their launch, thereby raising the bar for compounds in development
  • pharmaceutical companies might rethink their strategies for clinical trials
  • oo many companies commit a disproportionate amount of their time and money to discovering first-in-class compounds when best-in-class opportunities might yield higher returns
  • Second, efficacy shouldn't be pursued at the expense of other sources of differentiation; claims of safety, pharmacokinetics (that is, dosing), and convenience may be as desirable and more clinically attainable
  • one meaningful point of differentiation and scuttle drugs that have even a single subpar attribute.
  • Of the recent blockbusters we analyzed, 59 percent were superior to the competition in only one area, while just 14 percent were superior in two, and no drug was the leader in three or more (Exhibit 3). While some of the remaining 27 percent were distinctive at launch, they are now comparable to their competitors in all significant dimensions but continue to be marketed more effectively. Yet drugs with even a single subpar attribute were generally commercial failures.1

    These

hamelinclara

Telemedicine Deemed Critical for Rural Pediatric Care | mHealthWatch - 0 views

  •  
    ""The bottom line is that this readily available technology can and should be used to improve the quality of care delivered to critically ill children when there are no pediatric specialists available in their own communities," said James Marcin, director of the UC Davis Children's Hospital Pediatric Telemedicine Program and the study's senior author. "People say a picture is worth a thousand words," said Marcin, professor in the Department of Pediatrics, "With medicine, video conferencing brings us right to the bedside, allowing us to see what's happening and collaborate with on-site doctors to provide the best possible care to our patients.""
hamelinclara

PharmTech Talk » Social Media and the Pharma Industry - 0 views

  • For the pharmaceutical industry, social media poses concerns that range from release of propriety information to regulatory constraints to patient safety. These concerns have limited the industry’s use of a potential marketing and networking tool. Other industries are using Twitter, Facebook, and other social media outlets to promote products, follow consumer trends, and connect directly with their consumers. Is social media being used effectively at all in the pharmaceutical industry? Are there ways social media can be positively used by industry members to share ideas, connect with industry members, or even promote products? And if there is a fear of regulatory infractions, what can or should FDA and other international regulatory agencies do to promote the use of social media?
hamelinclara

Pressure mounts to end US pharma pay-for-delay deals - FRANCE 24 - 0 views

  • US senators are introducing legislation to end pay-off deals that keep generic drugs off shelves and give pharmaceutical giants market exclusivity that costs consumers billions of dollars per year.
  • pay-for-delay" agreements
hamelinclara

Trius: In An About Face, Congress Is Helping Biotech Companies That Are Developing Anti... - 0 views

  • The implications for Trius (TSRX) and other leading biotechnology companies involved in antibiotics development are profound.
  • ost large pharmaceutical and biotechnology firms have avoided antibiotics for much of the past two decades in large part due to the intrusion of Congress into the regulatory process
  • The most visible sign of this shift in attitude came from Congress with the passage of the Generating Antibiotics Incentives Now Act or GAIN which became effective on October 1, 2012. This was intended to spur development of new antibiotics through streamlining a regulatory process which has been oppressive for much of the last decade. Responding to the prompting of Congress, I expect the FDA to approach regulatory approval of new antibiotics with the same sense of urgency as drugs for cancer. The end result will be quicker approval of new drugs and new indications for existing antibiotics.
  • ...3 more annotations...
  • Antibiotics were major drivers of sales growth for the pharmaceutical industry in the 1970s, 1980s and early 1990s which caught the attention of the industry's many critics. A consensus developed among politicians, consumer groups and payors that there was no need for new antibiotics as most bacteria were susceptible to existing products. They saw new antibiotics as offering no advantages over existing drugs even though they were priced many times higher. Faced with this hostile environment, drug companies began to de-emphasize antibiotic research and focus on trendy new areas like depression, cholesterol lowering, gastrointestinal reflux disease, etc.
  • Adding to the move away from antibiotic development was considerable scrutiny about side effects that the industry came under in the early part of the 2000s. A major catalyst for this was the Vioxx side effect issues that caused Merck (MRK) to withdraw this anti-inflammatory drug from the market in 2004
  • ooking beyond the GAIN Act, infectious disease experts, FDA and industry are working on proposals for a new restricted approval pathway that would speed the development of new antibacterial drugs and could address some of the economic disincentives that have driven most pharma companies out of the space. A drug's safety and effectiveness would be studied in substantially smaller, more rapid, and less expensive clinical trials, like those typically used to support Orphan Drug approvals. They would be narrowly indicated for use in small, well-defined populations of patients for whom the drugs' benefits have been shown to outweigh their risks. It would slash the number of patients required to gain approval from about 1,400 for the typical antibiotic indication to 100 or less, cut development time in half, and reduce regulatory uncertainty
hamelinclara

Prévisions et tendances biopharmaceutiques (en anglais) | IMS Institute | Poi... - 0 views

  • 12 juil. 2012 Global Use of Medicines: Outlook through 2016 3 avr. 2012 Use of Medicines in the United States: Review of 2011 31 janv. 2012 White Paper: Shaping the Biosimilars Opportunity: A Global Perspective on the Evolving Biosimilars Landscape 18 mai 2011 IMS Institute Forecasts Global Spending on Medicines to Reach Nearly $1.1 Trillion by 2015 19 avr. 2011 IMS Institute Reports U.S. Spending on Medicines Grew 2.3 Percent in 2010, to $307.4 Billion
  • biopharmaceutiques (en anglais) Informations et commentaires concernant le secteur biopharmaceutique (en anglais) Réseau de recherches dans les services de santé Global Health Research Program
hamelinclara

Biopharmaceutics - Wikipedia, the free encyclopedia - 0 views

  • Biopharmaceutics is the field of study concerning biopharmaceuticals, medical drugs (see pharmacology) produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulence of viruses and bacteria is reduced by the process of attenuation, they can be used for therapeutic or in vivo diagnostic purposes, and are produced by means other than direct extraction from a native (non-engineered) biological source
  • Biopharmaceuticals may be produced from microbial cells (e.g. recombinant E. coli or yeast cultures), mammalian cell lines (see cell culture) and plant cell cultures (see plant tissue culture) and moss plants in bioreactors of various configurations, including photo-bioreactors.[4] Important issues of concern are cost of production (a low volume, high purity product is desirable) and microbial contamination (by bacteria, viruses, mycoplasma, etc.). Alternative platforms of production which are being tested include whole plants (plant-made pharmaceuticals).
hamelinclara

Understanding new influences acting on healthcare practitioners: Gaining a 360-degree v... - 0 views

  • healthcare practitioners (HCPs)
  • 1. Managed care-driven2. Patient-driven3. Technology-driven
  • The following questions are being tested in industry research to better characterize the new influences and to set up more insightful metrics of brand performance: How does the influence affect the strength of the relationship between the prescriber, company, and brand?  Can relationships with HCPs be strengthened by indirect influences, such as social media?  Regular assessment of relationship strength and corresponding value delivered is critical for brands operating under new commercial models. How does the influence support or contradict the brand's value proposition?  One metric to consider is believability of the brand's message in light of new influences being exercised. For example, peer-to-peer experiential dialog via the Internet may substantiate or significantly weaken the brand's claims. A metric of "customer alignment" is required and can be quantified by mining the dialog. To what extent does the influence help or hurt company communication and education efforts, including personal promotion?  The emergence of widely accessible technologies for sharing information has the potential to spread incomplete, biased, or worse, inaccurate information, which may change the nature of discussions between reps and HCPs. Field organizations must understand and address misconceptions and objections that develop more quickly in today's highly-connected environment. At the heart of today's influences are two related goals: containing costs and understanding comparative effectiveness. Measurement programs need to consider both these drivers to effectively evaluate brand performance. Measuring the impact of a pharmaceutical
  • ...5 more annotations...
  • brand on patient outcomes and cost containment is still in its infancy as a commercial business practice. However, new metrics about cost and value are taking shape, even if they are not yet on the brand's balanced scorecard or performance dashboard. A good starting point for using new metrics is to assign them only to new influences initially. They could then be expanded to traditional promotion and education activities.
  • Penetration: increase in the number of active presribers of the brand   Treatment Rates: increase in patients diagnosed and treated Disease Intervention Rates: decrease in the time to assess and treat first-line failures Patient Compliance/Adherence: increase in patient compliance with regimen
  • The first step is expanding (or at least re-deploying) resources for measuring the extent of HCP exposure to influence sources and the resulting behavioral change. Commercial analytics teams can begin by creating an influence map indicating the corresponding sources of data available
  • As a second step, brand managers should look for gaps between the findings and their brand strategy and promotion plans. Within the brand plan, it is helpful to include a list of major influences acting on HCPs and to plan a set of programs against these influences. Each year, the brand plan should have a few promotional "R&D" elements that offer more insight into the impact of new influences and how well the brand team is addressing them.
  • Once influences are identified, prioritized, and included in the brand plan for observation and future action, the third step-tracking and assessing impact-can begin. This involves adding a few Key Performance Indicators (KPIs) such as brand penetration, productivity, and adherence on the brand dashboard to monitor the spread of the influence, and to track how well the brand is responding to these influences.
hamelinclara

How Pharma Companies Use Social Media | Business 2 Community - 1 views

  • branded (sponsored and monitored by a specific brand), non-branded (usually support groups, fundraisers or information-based platforms like WebMD), and healthcare professional communities
  • acebook, Twitter and YouTube, as well as blogs (sponsored and non-sponsored)
  • a lot of opportunity for more engagement and creating educational communities onlin
  • ...2 more annotations...
  • Mayo Clinic did with live tweet chats.
  • to improve business efficiency
hamelinclara

Drug Makers Join Efforts in Research - NYTimes.com - 1 views

  • One project would be to standardize the way data from clinical trials are recorded. That would make it easier for clinical trial investigators to enter data without having to remember each company’s format and to compare data from clinical trials. Similarly, TransCelerate will work on a common Internet portal that investigators can use to communicate with all drug companies, and also on standardizing efforts to qualify clinical trial sites and to train investigators. It will also work on a way for companies to easily procure one another’s already marketed drugs for use in comparative clinical trials.
hamelinclara

IHE.net Home - 0 views

  • IHE is an initiative by healthcare professionals and industry to improve the way computer systems in healthcare share information. IHE promotes the coordinated use of established standards such as DICOM and HL7 to address specific clinical need in support of optimal patient care. Systems developed in accordance with IHE communicate with one another better, are easier to implement, and enable care providers to use information more effectively.
hamelinclara

Startup Incubator, Health Wildcatters Unveils First Class of Startups - 0 views

  •  
    "Here is a brief introduction Health Wildcatters inaugural class of 12 startups: 20over8 develops a vision testing system that goes beyond the standard eye chart to reflect realistic, real-world testing conditions. Care Starter is an app that gives patients access to information and resources to help them manage their life with a chronic medical condition. Cariloop hosts a digital platform to access real time information about geriatric care and service providers. Fraud ID Standard Technology is a patent pending system of preventing healthcare fraud through a real-time database system. KinesioKinect enables the mainstream use of mobile technologies and motion sensors to lower healthcare costs while improving patient outcomes. MakeMyPlate is a smart engine that guides the decision making process for daily food intake by making the process visual, fun, and easy. MyCounsel delivers mental healthcare providers and consumers greater access to data-based care, while improving many broader societal issues. NeuroTek develops a non-invasive, electronic neuromodulation devices for the treatment of migraines and other diseases. PT PAL's app stores, schedules and tracks personal physical therapy exercises in a way that is intuitive and convenient while also tracking compliance. Remind Technologies develops patient-centric medication adherence technologies that allow patients to be in charge of their own health. Socrates Health Solutions has invented a non-invasive blood glucose monitoring system. SPAtaneity is a professional nail salon experience for those living with diabetes, cancer, and other immune-suppressed conditions"
hamelinclara

'OK Glass, Save A Life.' The Application Of Google Glass In Sudden Cardiac Death - Forbes - 0 views

  •  
    "Google GOOG -0.32% Glass has made its way into healthcare.  Its use in the operating room and in medical education has been profiled here.  Yet the magic of Glass will be found in the applications that can make this "technology" into real-world solutions for health and medicine.  It's a bit like the smart phone and how its realization is a function of the countless apps that bring the device to life. Inside The Operating Room With Google Glass John Nosta Contributor Christian Assad, MD has taken the next step with Glass and developing a practical app that can turn Glass into a real life-saver. He recently profiles this application on his blog and I believe it's an important turn of events that showcase just how technology can be applied to medicine and public health issues.  Here's how it presents the concept in his blog-Google Glass and augmented CPR:"
hamelinclara

Infographic: More Patients Sharing Their Internet Medical Discoveries with Doctors | mH... - 0 views

  •  
    "Chalk this up as the most interesting infographic we've seen in some time. Health communication specialist Kathleen Hoffman, PhD, and the team at Medivizor recently created a fascinating visual depicting how how Patients discuss Internet health information with their doctors. Using data derived from a 2013 survey, the new infographic paints a riveting portrait of how patients are sharing information that they find on the Internet with their doctors. To learn more about the findings, check out the infographic below."
hamelinclara

China bypasses Big Pharma patents, authorizes low-cost generic drug manufacturing - 0 views

  • The Chinese government has officially amended its patent laws to allow drug companies to reproduce generic, low-cost versions of expensive
  • China is considering further strengthening its legal framework, so as to make use of legal space to produce generic drugs
1 - 20 of 48 Next › Last »
Showing 20 items per page